109 results on '"Rehwinkel, Jan"'
Search Results
2. HSV-1 employs UL56 to antagonize expression and function of cGAMP channels
3. A simple transwell-based infection system for obtaining pure populations of VZV-infected cells
4. Chemotherapy-induced transposable elements activate MDA5 to enhance haematopoietic regeneration
5. cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing
6. Fractional response analysis reveals logarithmic cytokine responses in cellular populations
7. Redox homeostasis maintained by GPX4 facilitates STING activation
8. A Balancing Act: MDA5 in Antiviral Immunity and Autoinflammation
9. Nitro-fatty acids are formed in response to virus infection and are potent inhibitors of STING palmitoylation and signaling
10. Antiviral activity of bone morphogenetic proteins and activins
11. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate
12. ZBP1 activation triggers hematopoietic stem and progenitor cell death resulting in bone marrow failure in mice.
13. Mitochondrial double-stranded RNA triggers antiviral signalling in humans
14. PA-X antagonises MAVS-dependent accumulation of early type I interferon messenger RNAs during influenza A virus infection
15. RNA degradation in antiviral immunity and autoimmunity
16. A G1‐like state allows HIV‐1 to bypass SAMHD1 restriction in macrophages
17. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage
18. 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice.
19. RECONsidering Sensing of Cyclic Dinucleotides
20. Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates
21. Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.
22. Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.
23. Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication.
24. Human ZBP1 induces cell death‐independent inflammatory signaling via RIPK3 and RIPK1.
25. Exposing Viruses: RNA Patterns Sensed by RIG-I-like Receptors
26. Keeping your armour intact: How HIV-1 evades detection by the innate immune system: HIV-1 capsid controls detection of reverse transcription products by the cytosolic DNA sensor cGAS
27. Varicella‐Zoster virus ORF9 is an antagonist of the DNA sensor cGAS.
28. The interferon-inducible GTPase MxB promotes capsid disassembly and genome release of herpesviruses.
29. mRNA quality control: An ancient machinery recognizes and degrades mRNAs with nonsense codons
30. Nonsense-mediated mRNA decay: target genes and functional diversification of effectors
31. Aicardi-Goutières syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity
32. Hypoxia Regulates Endogenous Double-Stranded RNA Production via Reduced Mitochondrial DNA Transcription.
33. Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity.
34. RIGorous detection: exposing virus through RNA sensing
35. The RNA sensor MDA5 detects SARS-CoV-2 infection.
36. Multi-Modal Characterization of Monocytes in Idiopathic Pulmonary Fibrosis Reveals a Primed Type I Interferon Immune Phenotype.
37. Regulation and inhibition of the DNA sensor cGAS.
38. SAMHD1‐mediated dNTP degradation is required for efficient DNA repair during antibody class switch recombination.
39. Innate immunology in COVID-19--a living review. Part I: viral entry, sensing and evasion.
40. Deoxyguanosine is a TLR7 agonist.
41. Target-specific requirements for enhancers of decapping in miRNA-mediated gene silencing
42. mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes
43. Infection with a Brazilian isolate of Zika virus generates RIG‐I stimulatory RNA and the viral NS5 protein blocks type I IFN induction and signaling.
44. B Cells Producing Type I IFN Modulate Macrophage Polarization in Tuberculosis.
45. Sensing of viral and endogenous RNA by ZBP1/ DAI induces necroptosis.
46. Restriction by SAMHD1 Limits cGAS/STING-Dependent Innate and Adaptive Immune Responses to HIV-1.
47. Mouse superkiller-2-like helicase DDX60 is dispensable for type I IFN induction and immunity to multiple viruses.
48. Interferon induction held captive in tumor cells.
49. Mouse knockout models for HIV-1 restriction factors.
50. PNP inhibitors selectively kill cancer cells lacking SAMHD1.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.